

Cover Story
Free
By Matthew Bin Han Ong
The contract for operations and technical support at the Frederick National Laboratory for Cancer Research could be accepting proposals as early as next month—but NCI advisors said they are hoping to slow the recompetition process to reform the laboratory's mission.
In Brief


Drugs & Targets
Trending Stories
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - NCAB asks for help from administration as NCI deals with deluge of grant applications
- Trump’s tariffs on generic drugs are “another wrinkle in an already unstable system”
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
- Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab













